Patient stories ‘burn into your brain and colour in the lines,’ says Minister Butler

The profound capacity of medical technology to transform lives, extend survival and reshape healthcare delivery was the focus of MedTech on the Hill, hosted by the Medical Technology Association of Australia (MTAA) at Parliament House.

Opened by Liz Carnabuci, Chair of the MTAA Board and Vice President and Managing Director of Medtronic, the event brought together policymakers, industry leaders, clinicians and patients, showcasing how innovation is being translated into real-world patient outcomes and system-wide impact.

Federal Health Minister Mark Butler attended the event, with an unexpected change in timing allowing him to hear patient stories firsthand.

Reflecting on the significance of those stories, Minister Butler said “As someone who’s been doing this job a while, the patient stories have such a powerful impact. You remember them. They’re the ones that are burned into your brain and colour in the lines.”

He added, “Despite all the reports and PowerPoint presentations MTAA members bring to us, these stories were incredibly valuable and remind us how lucky we are to be living in this period of extraordinary technological revolution.”

Nadia Ali, living with congenital heart disease, shared a story shaped by a lifetime spent moving in and out of crisis, surgery and fragile recovery. Before she was old enough to understand the world around her, she was “already fighting to stay in it”.

Her life unfolded through repeated interventions, each one a turning point. Major surgery to replace her tricuspid valve and repair her mitral valve marked one defining moment. But just months later, she was back in theatre again, facing another open-heart surgery after her mitral valve ruptured, where she received the Edwards MITRIS RESILIA valve. Later that same day, she endured yet another procedure to repair an internal aortic bleed.

In telling her story, Nadia did not soften the fear or uncertainty of those moments, the sense of a future constantly held in suspension, never fully guaranteed, never fully her own. And yet, her reflection was anchored in something deeply grounded and profoundly human.

“Today I am here because of medical technology,” she said. “Those valve replacements didn’t just fix something inside my body, they gave me a new breath of life. They gave me energy, they gave me time. But more than that, they gave me hope. Hope I can be present in my life, hope that I can be a mother to my beautiful three daughters, and hope that I’m also around for a long time for my beautiful granddaughter.”

Her message to decision-makers carried enormous moral weight. Timely and equitable access are not abstract policy considerations, they are determinants of survival.

“Access matters and timing matters, because when it comes to something as vital as your heart, waiting is not just difficult, it can be the difference between life and death,” she said.

She also highlighted the persistent gap between expectations and reality for privately insured patients navigating complex funding pathways, particularly as novel medical technologies are delayed or rejected for inclusion on the Prescribed List (PL).

“I’m a private patient, I pay my premiums because I thought I’m covered, but I wasn’t. I was let down,” she emphasised. “I didn’t have access to the heart valve technology. This came at a cost, and thankfully for me, when I was denied access, my private hospital funded my valves for me or I would not be here today.”

Stephen Fabro, a Queensland sugar cane farmer, shared a different but equally powerful story.

After open-heart surgery and initial rehabilitation at the Mater Hospital, Stephen returned to a reality shaped by distance of around 120 kilometres between his rural property and specialist cardiac services in Townsville. For many patients in regional Australia, that distance alone is a barrier to care delivery.

Instead, Stephen was introduced to a virtual rehabilitation program delivered through Cardihab, allowing him to continue structured, clinically supported recovery from home while staying on-farm and maintaining family and work responsibilities. The program reduced the physical and emotional burden of travel, but more importantly, it maintained continuity of care, connecting him to clinicians and a support group through remote sessions, real-time monitoring and ongoing health tracking.

“The virtual rehab program was excellent. Step by step, it helped me get back to normal life,” he said. “I still have the app on my phone and it has been a guide since the surgery. It reminds me to take my medication twice a day, and I use it to record my weight, blood pressure, and exercise each week to show my doctors at my annual checkup.”

Closing the evening, Ian Burgess, CEO of MTAA, shifted the focus to persistent system-level policy challenges that are a barrier to equitable access.

“Tonight is all about the Australians whose lives have been changed by medical technology. Their stories remind us that that every policy, every funding decision ultimately comes back to people like Nadia and Stephen. It’s about giving people more time, certainty, and hope,” he said. “Yet too often we never move beyond pilots or projects, meaning that Australia misses out and patients miss out. The challenge is no longer proving that these technologies work, it’s around funding and scaling them so that Australians can benefit.”

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.